This website provides information about the role and activities of the European Medicines Agency in relation to the current H1N1 influenza ('swine flu') pandemic. It also provides information on the development and approval of medicines for use in the European Union (EU) during the pandemic.
Vaccines are one of the most effective means for preventing people from contracting influenza.
The following vaccines have received a positive recommendation from the Agency for use in the EU against the virus causing the current pandemic:
Read also:
Antiviral medicines can be used either to prevent people from contracting influenza or to treat them once they have contracted it.
The following antivirals authorised for use in the EU are active against the virus causing the current pandemic:
This section provides up-to-date information on the Agency's actions and decisions relating to the influenza pandemic.
This section provides guidance on the development and approval of pandemic influenza vaccines in the EU.
The European Medicines Agency and the national competent authorities of the EU Member States warn that criminal groups may take advantage of the pandemic to sell fake, adulterated or unauthorised antiviral medication or vaccines via the internet.
Members of the public who buy counterfeit or illicit copies of these medicines may be putting their own health, or that of their families, at risk.
